Follow
Katarzyna Danis-Włodarczyk
Katarzyna Danis-Włodarczyk
Verified email at osu.edu
Title
Cited by
Cited by
Year
Pseudomonas predators: understanding and exploiting phage–host interactions
J De Smet, H Hendrix, BG Blasdel, K Danis-Wlodarczyk, R Lavigne
Nature Reviews Microbiology 15 (9), 517-530, 2017
1892017
The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence
T Olszak, MM Shneider, A Latka, B Maciejewska, C Browning, ...
Scientific reports 7 (1), 16302, 2017
932017
A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections
K Danis-Wlodarczyk, D Vandenheuvel, HB Jang, Y Briers, T Olszak, ...
Scientific reports 6 (1), 28115, 2016
922016
Phage cocktail development for bacteriophage therapy: toward improving spectrum of activity breadth and depth
ST Abedon, KM Danis-Wlodarczyk, DJ Wozniak
Pharmaceuticals 14 (10), 1019, 2021
892021
Characterization of the newly isolated lytic bacteriophages KTN6 and KT28 and their efficacy against Pseudomonas aeruginosa biofilm
K Danis-Wlodarczyk, T Olszak, M Arabski, S Wasik, ...
PloS one 10 (5), e0127603, 2015
822015
In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
T Olszak, P Zarnowiec, W Kaca, K Danis-Wlodarczyk, D Augustyniak, ...
Applied microbiology and biotechnology 99, 6021-6033, 2015
622015
Phage therapy: the pharmacology of antibacterial viruses
K Danis-Wlodarczyk, K Dąbrowska, ST Abedon
Current issues in molecular biology 40 (1), 81-164, 2021
602021
Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application
KM Danis-Wlodarczyk, DJ Wozniak, ST Abedon
Antibiotics 10 (12), 1497, 2021
552021
Phage therapy in the 21st century: is there modern, clinical evidence of phage-mediated efficacy?
ST Abedon, KM Danis-Wlodarczyk, DR Alves
Pharmaceuticals 14 (11), 1157, 2021
412021
New Bacteriophages against Emerging Lineages ST23 and ST258 of Klebsiella pneumoniae and Efficacy Assessment in Galleria mellonella Larvae
D Thiry, V Passet, K Danis-Wlodarczyk, C Lood, J Wagemans, L De Sordi, ...
Viruses 11 (5), 411, 2019
402019
A giant Pseudomonas phage from Poland
Z Drulis-Kawa, T Olszak, K Danis, G Majkowska-Skrobek, HW Ackermann
Archives of virology 159, 567-572, 2014
392014
Integrative omics analysis of Pseudomonas aeruginosa virus PA5oct highlights the molecular complexity of jumbo phages
C Lood, K Danis‐Wlodarczyk, BG Blasdel, HB Jang, D Vandenheuvel, ...
Environmental Microbiology 22 (6), 2165-2181, 2020
382020
Pseudomonas aeruginosa PA5oct Jumbo Phage Impacts Planktonic and Biofilm Population and Reduces Its Host Virulence
T Olszak, K Danis-Wlodarczyk, M Arabski, G Gula, B Maciejewska, ...
Viruses 11 (12), 1089, 2019
352019
Translating phage therapy into the clinic: recent accomplishments but continuing challenges
A Petrovic Fabijan, J Iredell, K Danis-Wlodarczyk, R Kebriaei, ST Abedon
Plos Biology 21 (5), e3002119, 2023
242023
Improving phage-biofilm in vitro experimentation
ST Abedon, KM Danis-Wlodarczyk, DJ Wozniak, MB Sullivan
Viruses 13 (6), 1175, 2021
222021
Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of Pseudomonas aeruginosa Phages
KM Danis-Wlodarczyk, A Cai, A Chen, MR Gittrich, MB Sullivan, ...
Pharmaceuticals 14 (11), 1162, 2021
172021
The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence. Sci Rep 7: 16302
T Olszak, MM Shneider, A Latka, B Maciejewska, C Browning, ...
132017
Genomic, transcriptomic, and structural analysis of Pseudomonas virus PA5oct highlights the molecular complexity among Jumbo phages
K Danis-Wlodarczyk, BG Blasdel, HB Jang, D Vandenheuvel, JP Noben, ...
BioRxiv, 406421, 2018
72018
Improving Phage-Biofilm In Vitro Experimentation. Viruses 2021, 13, 1175
ST Abedon, KM Danis-Wlodarczyk, DJ Wozniak, MB Sullivan
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
12021
In vitro analysis of colistin and ciprofloxacin antagonism of Pseudomonas aeruginosa phage PEV2 infection activities
K Danis-Wlodarczyk, A Cai, A Chen, M Gittrich, MB Sullivan, DJ Wozniak, ...
bioRxiv, 2020.12. 02.406561, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20